Patent · US Active

Methods and compositions for genome engineering

US10081661B2 · kind B2 · utility

6Cited by
49References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2014
Grant dateSep 25, 2018
Priority date
Expiry dateDec 9, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for insertion of transgene sequences encoding proteins that is aberrantly expressed in disease or disorder such as a lysosomal storage disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.